STOCK TITAN

ASP Isotopes (ASPI) Files Rule 144 Notice for 75k Shares on NASDAQ

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

ASP Isotopes Inc. (ASPI) filed a Form 144 notifying the proposed sale of 75,000 shares of its common stock through Independent Trading Group (ITG) on the NASDAQ with an aggregate market value of $789,750. The filer acquired 200,000 shares as a restricted stock award on August 16, 2023, paid by equity compensation on that date. The approximate date of sale is listed as August 29, 2025. The filing reports no securities sold during the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.

Positive

  • Transparent disclosure of the proposed sale with broker, venue, quantity, and aggregate value
  • Clear acquisition history showing the shares were received as restricted stock award on 08/16/2023
  • No sales in the past three months reported, simplifying aggregation considerations under Rule 144

Negative

  • None.

Insights

TL;DR: Routine Rule 144 notice for a planned sale of restricted shares; transaction size is small relative to outstanding shares.

The filing documents a proposed sale under Rule 144 of 75,000 common shares valued at $789,750 to be executed via ITG on Nasdaq. The shares were originally issued as restricted stock compensation (200,000 shares) on August 16, 2023, and payment was in equity compensation. No sales were reported in the prior three months, which supports Rule 144 aggregation disclosures. Based solely on the filing, this appears to be a compliance disclosure rather than a material corporate event.

TL;DR: Disclosure aligns with required insider sale notifications; includes requisite seller representation about material information.

The Form 144 contains the required seller attestations and transaction details: broker, execution venue, class, quantity, and acquisition provenance (restricted award). It also notes the filer represents no undisclosed material adverse information. The filing provides sufficient procedural detail to satisfy Rule 144 notice requirements but does not present governance changes or new corporate actions.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does ASPI's Form 144 disclose about the planned sale?

The filing discloses a proposed sale of 75,000 common shares via Independent Trading Group on NASDAQ with an aggregate market value of $789,750 and an approximate sale date of 08/29/2025.

How were the shares being sold by ASPI acquired?

The shares were acquired as a restricted stock award from the issuer on 08/16/2023, with 200,000 shares shown as acquired and payment recorded as equity compensation.

Does the Form 144 report any recent sales by the filer?

No; the filing states Nothing to Report for securities sold during the past three months.

Where will the proposed ASPI sale be executed and through which broker?

The sale is planned to be executed on the NASDAQ through Independent Trading Group (ITG), located at the address given in the filing.

What representation does the filer make about material information?

By signing the notice, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.
ASP Isotopes

NASDAQ:ASPI

View ASPI Stock Overview

ASPI Rankings

ASPI Latest News

ASPI Latest SEC Filings

ASPI Stock Data

731.89M
107.41M
Chemicals
Miscellaneous Chemical Products
Link
United States
WASHINGTON